The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenetic implications for vascular diseases

Cardiovascular Research

Volumn 75, Issue 1, 2007, Pages 21-28

  Minetti, Maurizio ^a   Agati, Luciano ^b   Malorni, Walter ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Biomarkers; Erythrocyte; Redox; Vascular complications; Vascular diseases

Indexed keywords

BIOLOGICAL MARKER; CARBON DIOXIDE; NITRIC OXIDE; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BLOOD VESSEL INJURY; CAPILLARY; CARDIOVASCULAR DISEASE; CELL FUNCTION; CIRCULATION; DISEASE COURSE; ENDOTHELIUM; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE STRUCTURE; HUMAN; MICROENVIRONMENT; MORBIDITY; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ANTIOXIDANTS; APOPTOSIS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 34249905911     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.03.007     Document Type: Review

References (73)

1. Jia L., Bonaventura C., Bonaventura J., and Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380 (1996) 221-226
2. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9 (2003) 1498-1505
3. Marchesi V.T. Stabilizing infrastructure of cell membranes. Annu Rev Cell Biol 1 (1985) 531-561
4. An X., Lecomte M.C., Chasis J.A., Mohandas N., and Gratzer W. Shear-response of the spectrin dimer-tetramer equilibrium in the red blood cell membrane. J Biol Chem 277 (2002) 31796-31800
5. Streichman S., Hertz E., and Tatarsky I. Direct involvement of spectrin thiols in maintaining erythrocyte membrane thermal stability and spectrin dimer self-association. Biochim Biophys Acta 942 (1988) 333-340
6. Boas F.E., Forman L., and Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 95 (1998) 3077-3081
7. Buehler P.W., and Alayash A.I. Oxygen sensing in the circulation: "cross talk" between red blood cells and the vasculature. Antioxid Redox Signal 6 (2004) 1000-1010
8. Minetti M., and Malorni W. Redox control of red blood cell biology: the red blood cell as a target and source of prooxidant species. Antioxid Redox Signal 8 (2006) 1165-1169
9. Lucantoni G., Pietraforte D., Matarrese P., Gambardella L., Metere A., Paone G., et al. The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. Antioxid Redox Signal 8 (2006) 1171-1182
10. Rogowski O., Berliner S., Zeltser D., Serov J., Ben-Assayag E., Justo D., et al. The erythrosense as a real-time biomarker to reveal the presence of enhanced red blood cell aggregability in atherothrombosis. Am J Ther 12 (2005) 286-292
11. Kesler A., Yatziv Y., Shapira I., Berliner S., and Assayag E.B. Increased red blood cell aggregation in patients with idiopathic intracranial hypertension. A hitherto unexplored pathophysiological pathway. Thromb Haemost 96 (2006) 483-487
12. Martin F.A., Bydlon G., and Friedman J.S. SOD2-deficiency, sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal 8 (2006) 1217-1225
13. Nickel C., Rahlfs S., Deponte M., Koncarevic S., and Becker K. Thioredoxin networks in the malarial parasite Plasmodium falciparum. Antioxid Redox Signal 8 (2006) 1227-1239
14. Kennett E.C., and Kuchel P.W. Plasma membrane oxidoreductases: effects on erythrocyte metabolism and redox homeostasis. Antioxid Redox Signal 8 (2006) 1241-1247
15. Fonseca A.M., Porto G., Uchida K., and Arosa F.A. Red blood cell inhibits activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes. Blood 97 (2001) 3152-3160
16. Crawford J.H., Isbell T.S., Huang Z., Shiva S., Chacko B.K., Schechter A.N., et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107 (2006) 566-574
17. Angelo M., Singel D.J., and Stamler J.S. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci U S A 103 (2006) 8366-8371
18. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 107 (2006) 2943-2951
19. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
20. Fialkow L., Wang Y., and Downey G.P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42 (2007) 153-164
21. Fonseca A.M., Pereira C.F., Porto G., and Arosa F.A. Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress. Free Radic Biol Med 35 (2003) 1404-1416
22. Richards R.S., Roberts T.K., Dunstan R.H., McGregor N.R., and Butt H.L. Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage. Biochem Mol Biol Int 46 (1998) 857-865
23. Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 49 (2005) 1063-1071
24. Leonarduzzi G., Chiarpotto E., Biasi F., and Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 49 (2005) 1044-1049
25. Crawford J.H., Chacko B.K., Kevil C.G., and Patel R.P. The red blood cell and vascular function in health and disease. Antioxid Redox Signal 6 (2004) 992-999
26. Goldstein S., and Samuni A. Intra- and intermolecular oxidation of oxymyoglobin and oxyhemoglobin induced by hydroxyl and carbonate radicals. Free Radic Biol Med 39 (2005) 511-519
27. Grinshtein N., Bamm V.V., Tsemakhovich V.A., and Shaklai N. Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. Biochemistry 42 (2003) 6977-6985
28. Comporti M., Signorini C., Buonocore G., and Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 32 (2002) 568-576
29. Signorini C., Ferrali M., Ciccoli L., Sugherini L., Magnani A., and Comporti M. Iron release, membrane protein oxidation and erythrocyte ageing. FEBS Lett 362 (1995) 165-170
30. Iuliano L., Violi F., Pedersen J.Z., Pratico D., Rotilio G., and Balsano F. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch Biochem Biophys 299 (1992) 220-224
31. Casado J.A., Merino J., Cid J., Subira M.L., and Sanchez-Ibarrola A. The type of interaction with Fc gamma R in human monocytes determines the efficiency of the generation of oxidative burst. Immunology 83 (1994) 148-154
32. Yelinova V., Glazachev Y., Khramtsov V., Kudryashova L., Rykova V., and Salganik R. Studies of human and rat blood under oxidative stress: changes in plasma thiol level, antioxidant enzyme activity, protein carbonyl content, and fluidity of erythrocyte membrane. Biochem Biophys Res Commun 221 (1996) 300-303
33. Konukoglu D., Kemerli G.D., Sabuncu T., and Hatemi H.H. Protein carbonyl content in erythrocyte membranes in type 2 diabetic patients. Horm Metab Res 34 (2002) 367-370
34. Bierhaus A., Hofmann M.A., Ziegler R., and Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37 (1998) 586-900
35. Schmidt A.M., and Stern D. Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 2 (2000) 430-436
36. Singh R., Barden A., Mori T., and Beilin L. Advanced glycation end-products: a review. Diabetologia 44 (2001) 129-146
37. Daugas E., Cande C., and Kroemer G. Erythrocytes: death of a mummy. Cell Death Differ 8 (2001) 1131-1133
38. Lang F., Lang K.S., Lang P.A., Huber S.M., and Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal 8 (2006) 1183-1192
39. Matarrese P., Straface E., Pietraforte D., Gambardella L., Vona R., Maccaglia A., et al. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 19 (2005) 416-418
40. Head D.J., Lee Z.E., Poole J., and Avent N.D. Expression of phosphatidylserine (PS) on wild-type and Gerbich variant erythrocytes following glycophorin-C (GPC) ligation. Br J Haematol 129 (2005) 130-137
41. Pietraforte D., Matarrese P., Straface E., Gambardella L., Metere A., Scorza G., et al. Two different pathways are involved in peroxynitrite-induced senescence and apoptosis of human erythrocytes. Free Radic Biol Med 42 (2007) 202-214
42. Fusman G., Mardi T., Justo D., Rozenblat M., Rotstein R., Zelster D., et al. Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol 90 (2002) 561-563
43. Straface E., Matarrese P., Gambardella L., Forte S., Carlone S., Li Bianchi E., et al. N Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 279 (2000) 552-556
44. Yasin Z., Witting S., Palascak M.B., Joiner C.H., Rucknagel D.L., and Franco R.S. Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 102 (2003) 365-370
45. Kuypers F.A., Yuan J., Lewis R.A., Snyder L.M., Kiefer C.R., Bunyaratvej A., et al. Membrane phospholipid asymmetry in human thalassemia. Blood 91 (1998) 3044-3051
46. Vaya A., Iborra J., Falco C., Moreno I., Bolufer P., Ferrando F., et al. Rheological behaviour of red blood cells in beta and deltabeta thalassemia trait. Clin Hemorheol Microcirc 28 (2003) 71-78
47. Bonomini M., Sirolli V., Settefrati N., Dottori S., Di Liberato L., and Arduini A. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 10 (1999) 1982-1990
48. Sabolovic D., Roudier M., Boynard M., Pautou C., Sestier C., Fertil B., et al. Membrane modifications of red blood cells in Alzheimer's disease. J Gerontol Ser A Biol 52 (1997) 217-220
49. Lominadze D., and Dean W.L. Involvement of fibrinogen specific binding in erythrocyte aggregation. FEBS Lett 517 (2002) 41-44
50. Manodori A.B., Barabino G.A., Lubin B.H., and Kuypers F.A. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 95 (2000) 1293-1300
51. Simon E., Paul J.L., Atger V., Simon A., and Moatti N. Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. Atherosclerosis 138 (1998) 375-381
52. Szapary L., Horvath B., Marton Z., Alexy T., Kesmarky G., Habon T., et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs 18 (2004) 165-172
53. Dujovne C.A., Harris W.S., Altamn R., Overhiser R.W., and Black D.M. Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol 85 (2000) 350-353
54. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., and Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
55. Jørgensen E., Bindslev L., Ripa R.S., and Kastrup L. Epo 'cytokine-doping' of heart disease patients, will it work?. Eur Heart J 27 (2006) 1767-1768
56. Szikszai Z., Ujhelyi L., and Imre S.G. Effect of hemodialysis on the deformability and lipid peroxidation of erythrocytes in chronic renal failure. Clin Hemorheol Microcirc 28 (2003) 201-207
57. Chattopadhyay A., Choudhury T.D., Bandyopadhyay D., and Datta A.G. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59 (2000) 419-425
58. Choudhury T.D., Das N., Chattopadhyay A., and Datta A.G. Effect of oxidative stress and erythropoietin on cytoskeletal protein and lipid organization in human erythrocytes. Pol J Pharmacol 51 (1999) 341-350
59. Sayan H., Ozacmak V.H., Guven A., Aktas R.G., and Ozacmak I.D. Erythropoietin stimulates wound healing and angiogenesis in mice. J Invest Surg 19 (2006) 163-173
60. Chandel N.S., McClintock D.S., Feliciano C.E., Wood T.M., Melendez J.A., Rodriguez A.M., et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275 (2000) 25130-25138
61. Berliner S., Zeltser D., Shapira I., Assayag E.B., Mardi T., Serov J., et al. A simple biomarker to exclude the presence of low grade inflammation in apparently healthy individuals. J Cardiovasc Risk 9 (2002) 281-286
62. Sharshun Y., Brill S., Mardi T., Justo D., Rozenblat M., Goldin Y., et al. Inflammation at a glance: erythrocyte adhesiveness/aggregation test to reveal the presence of inflammation in people with atherothrombosis. Heart Dis 5 (2003) 182-183
63. Berliner S., Rogowski O., Aharonov S., Mardi T., Tolshinsky T., Rozenblat M., et al. Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J 149 (2005) 260-267
64. Reinhart W.H. Fibrinogen-marker or mediator of vascular disease?. Vasc Med 8 (2003) 211-216
65. Ben Assayag E., Bova I., Berliner S., Peretz H., Usher S., Shapira I., et al. Gender differences in the expression of erythrocyte aggregation in relation to B beta-fibrinogen gene polymorphisms in apparently healthy individuals. Thromb Haemost. 95 (2006) 428-433
66. Blankenberg S., Rupprecht H.J., Bickel C., Torzewski M., Hafner G., Tiret L., et al. AtheroGene investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349 (2003) 1605-1613
67. Ami R.B., Barshtein G., Zeltser D., Goldberg Y., Shapira I., Roth A., et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart C 280 (2001) H1982-H1988
68. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003) 2316-2325
69. Muda P., Kampus P., Zilmer M., Zilmer K., Kairane C., Ristimae T., et al. Homocysteine and red blood cell glutathione as indices for middle-aged untreated essential hypertension patients. J Hypertens 21 (2003) 2329-2333
70. Ekmekci O.B., Donma O., and Tunckale A. Angiotensin-converting enzyme and metals in untreated essential hypertension. Biol Trace Elem Res 95 (2003) 203-210
71. Anuk T., Assayag E.B., Rotstein R., Fusman R., Zeltser D., Berliner S., et al. Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand 106 (2002) 196-199
72. Setty B.N., Stuart M.J., Dampier C., Brodecki D., and Allen J.L. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 362 (2003) 1450-1455
73. Burgaud J.L., Riffaud J.P., and Del Soldato P. Nitric-Oxide releasing molecules: a new class of drugs with several major indications. Curr Pharm Des 8 (2002) 201-213